These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 24907379)

  • 1. Type I interferon in the pathogenesis of lupus.
    Crow MK
    J Immunol; 2014 Jun; 192(12):5459-68. PubMed ID: 24907379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I Interferons in Autoimmune Disease.
    Crow MK; Olferiev M; Kirou KA
    Annu Rev Pathol; 2019 Jan; 14():369-393. PubMed ID: 30332560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in understanding the role of type I interferons in systemic lupus erythematosus.
    Crow MK
    Curr Opin Rheumatol; 2014 Sep; 26(5):467-74. PubMed ID: 25010440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus.
    Wenzel J; Zahn S; Bieber T; Tüting T
    Arch Dermatol Res; 2009 Jan; 301(1):83-6. PubMed ID: 18784932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.
    Pollard KM; Escalante GM; Huang H; Haraldsson KM; Hultman P; Christy JM; Pawar RD; Mayeux JM; Gonzalez-Quintial R; Baccala R; Beutler B; Theofilopoulos AN; Kono DH
    J Immunol; 2017 Dec; 199(11):3739-3747. PubMed ID: 29055005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.
    Zhuang H; Han S; Xu Y; Li Y; Wang H; Yang LJ; Reeves WH
    Arthritis Rheumatol; 2014 Jan; 66(1):140-51. PubMed ID: 24449581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon and systemic lupus erythematosus.
    Elkon KB; Stone VV
    J Interferon Cytokine Res; 2011 Nov; 31(11):803-12. PubMed ID: 21859344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factors in human lupus pathogenesis.
    Salloum R; Niewold TB
    Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications.
    Xourgia E; Tektonidou MG
    J Autoimmun; 2019 Nov; 104():102311. PubMed ID: 31378637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
    Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
    Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
    Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.
    Zhuang H; Han S; Li Y; Kienhöfer D; Lee P; Shumyak S; Meyerholz R; Rosadzinski K; Rosner D; Chan A; Xu Y; Segal M; Sobel E; Yang LJ; Hoffmann MH; Reeves WH
    Arthritis Rheumatol; 2016 Dec; 68(12):2917-2928. PubMed ID: 27274010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
    Luo S; Wang Y; Zhao M; Lu Q
    Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.
    Lenert P
    Clin Exp Immunol; 2010 Aug; 161(2):208-22. PubMed ID: 20456414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.